Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,152 public trials 2,021 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

NCT05194995

Conditions
Advanced Colorectal Cancer, Appendiceal Cancer, Appendiceal Neoplasms, +11 more
Locations
  • Research site31 Beijing, Beijing Municipality, China
  • Research site01 Beijing, Beijing Municipality, China
  • Research site02 Beijing, Beijing Municipality, China
  • Research site12 Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details
Active, Not Recruiting

Cola Ingestion for Esophageal Bolus Impaction

NCT06652620

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Fudan University Shanghai Cancer Center Xiamen Hospital Xiamen, Fujian, China
  • The Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China
  • First People's Hospital Jingdezhen, Jiangxi, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT06256328

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Ehime, Japan
  • NHO Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 63 locations
View Trial Details
Active, Not Recruiting

Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)

NCT05382364

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +15 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Jilin Cancer Hospital Changchun, Jilin, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View Trial Details

Related conditions